A novel GPI-anchored dominant-negative TGF-β receptor II renders T cells unresponsive to TGF-β signaling

Sven Petersen(Aarhus University), John E. Connolly(Johns Hopkins Medicine)
Molecular Therapy — Oncolytics
September 25, 2023
Cited by 8


Related Papers